Specific antibody responses to an HIV-1 vaccine

被引：0

作者：

Sands, AR ^{[1
]}

Kent, SJ ^{[1
]}

Dax, EM ^{[1
]}

Johnson, EIM ^{[1
]}

机构：

[1] Natl Serol Reference Lab, Fitzroy, Vic, Australia

来源：

6TH EUROPEAN CONFERENCE ON EXPERIMENTAL AIDS RESEARCH | 2001年

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The specific humoral response to an anti-HIV-1 vaccine was characterised in five macaque monkeys. Antibody production corresponded to vaccine-encoded antigens. Antibody titre increased moderately but transiently in response to vaccination in three macaques. Antibody avidity was unaltered in all but one macaque in response to vaccination. Whilst this vaccine is aimed at inducing a T cell immune response, it is clear that a degree of vaccine-specific antibody production also occurs.

引用

页码：75 / 80

页数：6

共 50 条

[41] HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition
Prentice, Heather A.
Tomaras, Georgia D.
Geraghty, Daniel E.
Apps, Richard
Fong, Youyi
Ehrenberg, Philip K.
Rolland, Morgane
Kijak, Gustavo H.
Krebs, Shelly J.
Nelson, Wyatt
DeCamp, Allan
Shen, Xiaoying
Yates, Nicole L.
Zolla-Pazner, Susan
Nitayaphan, Sorachai
Rerks-Ngarm, Supachai
Kaewkungwal, Jaranit
Pitisuttithum, Punnee
Ferrari, Guido
McElrath, M. Juliana
Montefiori, David C.
Bailer, Robert T.
Koup, Richard A.
O'Connell, Robert J.
Robb, Merlin L.
Michael, Nelson L.
Gilbert, Peter B.
Kim, Jerome H.
Thomas, Rasmi
SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (296)
[42] Broad and potent neutralizing antibody responses in HIV-1 infected Angolan patients: implications for vaccine design and efficacy
Martin, F.
Palladino, C.
Mateus, R.
Diniz, A. R.
Calado, R.
Figueiredo, I.
Bartolo, I.
Borrego, P.
Clemente, S.
Taveira, N.
HIV MEDICINE, 2019, 20 : 310 - 310
[43] Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine
Lianxing Liu
Yanmin Wan
Lan Wu
Jianping Sun
Huiguang Li
Haishan Li
Liying Ma
Yiming Shao
Retrovirology, 7
[44] Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine
Liu, Lianxing
Wan, Yanmin
Wu, Lan
Sun, Jianping
Li, Huiguang
Li, Haishan
Ma, Liying
Shao, Yiming
RETROVIROLOGY, 2010, 7
[45] ANTIBODY TO SPECIFIC HIV-1 PROTEINS IN ORAL MUCOSAL TRANSUDATES
CHEINGSONGPOPOV, R
CALLOW, D
WEBER, J
HOLMHANSEN, C
CONSTANTINE, NT
LANCET, 1993, 341 (8861): : 1659 - 1660
[46] Induction of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses in HIV vaccine trial participants who subsequently acquire HIV-1 infection
Horton, Helen
Havenar-Daughton, Colin
Lee, Deborah
Moore, Erin
Cao, Jianhong
McNevin, John
Andrus, Thomas
Zhu, Haiying
Rubin, Abbe
Zhu, Tuofu
Celum, Connie
McElrath, M. Juliana
JOURNAL OF VIROLOGY, 2006, 80 (19) : 9779 - 9788
[47] HIV-1 vaccine design based on human vaccine trials to improve Gag, Pol, Nef and Env specific immune responses
Wild, J.
Kostler, J.
Bredl, S.
Bockl, K.
Kindsmueller, K.
Wagner, R.
RETROVIROLOGY, 2009, 6
[48] HIV-1 SPECIFIC IGG CAPTURE ENZYME-IMMUNOASSAY TO STUDY THE DYNAMICS OF HIV-1 ANTIBODY AND TO DIAGNOSE HIV-1 INFECTION IN INFANTS
PAREKH, B
SHAFFER, N
SCHOCHETMAN, G
COUGHLIN, RT
HUNG, CH
GEORGE, JR
PEDIATRIC AIDS: CLINICAL, PATHOLOGIC, AND BASIC SCIENCE PERSPECTIVES, 1993, 693 : 268 - 271
[49] T lymphocyte responses in HIV-1 infection: implications for vaccine development
Brander, C
Walker, B
CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (04) : 451 - 459
[50] Lymphoproliferative responses induced by HIV-1 immunogen vaccine children with HIV infection.
Ratto-Kim, S
Robb, M
Sandelli, S
Williams, M
Sei, S
Theofan, G
Diveley, J
Moss, RB
Venzon, D
Wood, LV
CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 220 - 220

← 1 2 3 4 5 →